Equities

Huakang Biomedical Holdings Co Ltd

Huakang Biomedical Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.116
  • Today's Change-0.002 / -1.69%
  • Shares traded4.25m
  • 1 Year change-39.90%
  • Beta-0.2024
Data delayed at least 15 minutes, as of Jul 04 2024 08:59 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Huakang Biomedical Holdings Co Ltd is an investment holding company mainly engaged in the production and sales of in-vitro diagnostic reagents. The Company operates its business through two segments. The Biological Reagents and Auxiliary Reproductive Supplies and Equipment segment is engaged in the research and development, production, marketing and sales of in-vitro diagnostic reagents, including male infertility in vitro diagnostic reagents, parasite series detection reagents and Epstein-Barr (EB) virus detection reagents. The Segment is also engaged in the manufacture and sale of auxiliary reproductive supplies and devices. The Healthcare Products and Supplements segment is engaged in the sales of health products and supplements.

  • Revenue in HKD (TTM)26.47m
  • Net income in HKD-6.21m
  • Incorporated2017
  • Employees96.00
  • Location
    Huakang Biomedical Holdings Co Ltd2/F, 100 Des Voeux Road Central, Central Hong KongHKG
  • Phone+852 22028989
  • Fax+852 22028989
  • Websitehttp://www.huakangbiomedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sinopharm Tech Holdings Ltd46.66m-28.92m22.59m18.00------0.4843-0.1585-0.15850.2548-0.95990.92849.652.292,455,684.00-55.93-57.76----11.9027.12-60.24-114.260.134-2.69----4.5211.0787.91------
China Regenerative Medicine Intl Ltd69.49m-107.70m48.68m46.00--4.13--0.7006-0.376-0.3760.24320.03880.3009136.97109.691,510,587.00-46.64-25.53-138.21-49.2627.9521.79-154.99-66.501.14-110.070.8097---70.00-0.9685-2,464.41---53.94--
Huakang Biomedical Holdings Co Ltd26.47m-6.21m58.05m96.00--0.8854--2.19-0.0149-0.01490.06360.1310.3742.692.57275,690.80-8.78-6.96-10.62-8.0164.4966.27-23.48-20.233.82--0.0429---2.77-3.00-88.03---12.03--
AMCO United Holding Ltd34.33m-1.71m71.60m30.00--1.17--2.09-0.0049-0.0060.03690.06340.2015.381.301,144,433.00-1.00-20.07-2.07-31.1043.1325.73-4.99-65.822.110.78960.3349---48.36-21.1098.36------
Grand Brilliance Group Holdings Ltd81.90m7.86m80.80m46.0010.290.7826.510.98650.00980.00980.10240.12920.7131.714.831,780,500.006.786.757.697.8351.2151.029.5110.017.1023.250.013739.866.787.133.873.52--14.87
China Ever Grand Financl Lasng Gp Co Ltd52.70m-40.41m89.43m62.00--0.1974--1.70-0.024-0.02290.03120.26840.08082.133.59850,032.30-6.20-9.34-8.31-16.1733.728.95-76.67-140.711.59-227.390.00---26.54-10.25-27.68---22.87--
BioSino Bio-technology and Science Inc310.64m-12.52m91.17m537.00--0.4032--0.2935-0.0865-0.08652.151.560.49562.791.46578,468.80-3.30-3.84-8.55-10.1744.0640.17-6.66-6.980.9033--0.3956---22.52-0.9513-243.70---16.58--
Yestar Healthcare Holdings Co Ltd3.13bn-10.01m95.60m713.00----0.84480.0305-0.0043-0.00641.34-0.21090.85726.822.634,389,932.000.0435-3.46---9.8217.6019.490.0507-4.090.69101.011.25--3.86-8.1197.98--20.66--
Kaisa Health Group Holdings Ltd185.88m7.47m105.88m893.0014.190.21524.410.56960.00150.00150.03690.09760.27081.332.05208,154.500.8961-14.171.21-17.6843.6246.353.31-56.143.33-1.540.0353---2.93-5.14106.06---16.75--
Golden Century Intrntnl Hold Grp Ltd114.72m-138.72m106.90m24.00------0.9318-0.0312-0.03190.0258-0.03430.57141,986.8623.792,868,075.00-69.01-51.42---118.761.2816.92-120.77-748.440.135--4.90--49.1221.83-146.27---25.75--
Sun Hing Vision Group Holdings Ltd702.34m-28.37m170.81m3.20k--0.2548--0.2432-0.1079-0.10792.672.550.75886.334.03---3.06-4.01-4.00-5.2710.6716.26-4.04-5.302.07-8.890.0735---0.3647-10.517.18------
Rainmed Medical Ltd78.68m-124.47m197.36m354.00--0.3566--2.51-0.1066-0.10660.06740.47390.11592.8438.14222,263.00-18.53---20.37--66.31---159.88--8.77--0.037---12.42--91.39------
Kelfred Holdings Ltd393.28m1.39m197.50m1.04k142.091.0816.770.50220.00280.00280.78660.36641.524.613.84377,070.000.53810.29570.7240.435814.4917.360.35290.19472.022.510.07670.0029-15.50-1.36-84.89-46.0726.80--
Data as of Jul 04 2024. Currency figures normalised to Huakang Biomedical Holdings Co Ltd's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.